Ignite Creation Date:
2025-12-24 @ 12:51 PM
Ignite Modification Date:
2026-02-02 @ 2:20 PM
Study NCT ID:
NCT04971161
Status:
COMPLETED
Last Update Posted:
2025-12-04
First Post:
2021-06-07
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of CVU (Phase IIb)
Sponsor:
RHEACELL GmbH & Co. KG
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
allo-APZ2-CVU-IIb
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |